Drug Name: Mepolizumab

Brand Name: NUCALA®

Medicine Use: Add-on therapy/long-term control

Type of Medicine: Biologic

Form: Injection

Prescribing Info: NUCALA (mepolizumab) injection prescribing information insert

Notes: NUCALA is a maintenance treatment for severe eosinophilic asthma. NUCALA is also approved for chronic rhinosinusitis with nasal polyposis, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome.

Possible Side Effects:
Headache
Injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site)
Back pain
Tiredness (fatigue)

Notes/Resources:
Learn more about Mepolizumab in pregnancy and while breastfeeding

Copay Assistance Programs

If you have commercial insurance: If you have a commercial medical or prescription insurance plan, you may be able to take part on the NUCALA Copay Program. If you are approved, the GSK Copay Program may help with your cost share for NUCALA and the your cost share for administration up to the total annual copay program maximums.

If you have government insurance or no insurance: You are not eligible for this program if you are covered by any federal or state prescription insurance program.

For more information, visit the NUCALA Copay Program website or call 800-691-1939.